Actinium Pharmaceuticals, Inc. (ATNM): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$900.0K
Year ended 2021-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $900.0K | n/a | 2022-03-25, From 2021-01-01 |